Systemic arterial hypertension as a risk factor for the severe form of covid-19: scoping review

Rev Saude Publica. 2022 Apr 8:56:20. doi: 10.11606/s1518-8787.2022056004311. eCollection 2022.
[Article in English, Portuguese]

Abstract

Objective: Identify whether systemic arterial hypertension is a risk factor for the severe form of covid-19.

Methods: This is a scoping review, searches were performed on the Lilacs, PubMed, SciELO and Web of Science databases.

Results: Thirteen articles were selected. The studies presented systemic arterial hypertension as the most common chronic disease in subjects diagnosed with covid-19. Hypertensive subjects were older, and men were more likely to develop severe covid-19. Hypertensive subjects without antihypertensive treatment were associated with a higher risk of mortality.

Conclusions: subjects with chronic diseases tend to have a different clinical profile. Blood pressure should be controlled in hypertensive subjects that should be continuously monitored during the covid-19 infection.

OBJETIVO: Identificar se a hipertensão arterial sistêmica se apresenta como um fator de risco para o agravamento da covid-19.

MÉTODOS: Trata-se de uma revisão de escopo, as buscas foram realizadas nas bases de dados Lilacs, PubMed, SciELO e Web of Science.

RESULTADOS: Foram selecionados 13 artigos. Os estudos apresentaram a hipertensão arterial sistêmica como a doença crônica mais comum em pacientes diagnosticados com covid-19. Os pacientes hipertensos eram mais velhos e os homens se apresentaram mais suscetíveis a desenvolver covid-19 grave. Pacientes hipertensos sem tratamento anti-hipertensivo foram associados a um maior risco de mortalidade.

CONCLUSÕES: Pacientes com doenças crônicas tendem a apresentar um perfil clínico diferente, sendo essencial controlar a pressão arterial em pacientes hipertensos e monitorá-los continuamente durante a infecção por covid-19.

Publication types

  • Review

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Brazil
  • COVID-19*
  • Chronic Disease
  • Female
  • Humans
  • Hypertension* / complications
  • Hypertension* / drug therapy
  • Hypertension* / epidemiology
  • Male
  • Risk Factors

Substances

  • Antihypertensive Agents

Grants and funding

Funding: Fundação de Amparo à Pesquisa do Estado de São Paulo (Fapesp - Process 2019/21219-7). Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq - Process 402507/2020-7).